Ceftriaxona I.V. Generis

Ceftriaxone I.V. Generis is a broad-spectrum antibiotic used for intravenous administration. It is effective against a wide range of bacterial infections, including severe cases. This medication is manufactured by Eugia Pharma (Malta) Ltd and is suitable for hospital and clinical settings.

Ceftriaxone I.V. Generis is primarily used to treat various bacterial infections, including those affecting the skin, respiratory tract, urinary tract, and more severe infections like sepsis and meningitis. It is often administered intravenously in clinical settings to ensure rapid and effective treatment. This antibiotic is known for its broad-spectrum activity, making it a versatile option for healthcare professionals.

Common effects of Ceftriaxone I.V. Generis may include mild to moderate reactions at the injection site, such as redness or swelling. Some patients may experience gastrointestinal discomfort, including nausea or diarrhea. These effects are generally temporary and should be monitored by a healthcare professional.

Ceftriaxone I.V. Generis should be handled with care, ensuring proper sterile techniques during administration. Patients with known allergies to cephalosporin antibiotics should inform their healthcare provider before use. It is important to follow the prescribed dosage and administration guidelines to minimize the risk of adverse reactions.

Ceftriaxone I.V. Generis may interact with certain medications, including other antibiotics and drugs that affect kidney function. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol consumption should be avoided during treatment to prevent adverse effects.